The regulatory network of “writer” METTL3, “reader” YTHDF1, and “target” FRAS1 inspires the understanding of m6A-dependent gene regulatory mechanism in cancer biology, which offers a possibility of m6A regulators as promising biomarkers in NSCLC. This evidence concerns the gene FRAS1 and non-small cell lung carcinoma.